This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A second discussion of the use of Actemra for patients with severe Covid-19 infections in light of its recent FDA approval

Ticker(s): RHHBY

Who's the expert?

Institution: SUNY Downstate Medical Center

  • Pulmonary and Critical Care Physician and Internal Medicine
  • treats few severe Covid patients recently but has taken care of hundreds and hundreds in the past two years being in Brooklyn.

Interview Goal
Discussing the impact of the FDA approval of Actemra

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.